中华胃肠外科杂志Pub Date : 2023-11-25DOI: 10.3760/cma.j.cn441530-20230826-00069
Y M Jiang, J Jia, Q Zhong, Q Y Chen, J Lu, J B Wang, J W Xie, P Li, Z H Zheng, C M Huang, X Y Li, J X Lin
{"title":"[Establishment of a nomogram prediction model using common preoperative indicators for early weight loss after laparoscopic sleeve gastrectomy].","authors":"Y M Jiang, J Jia, Q Zhong, Q Y Chen, J Lu, J B Wang, J W Xie, P Li, Z H Zheng, C M Huang, X Y Li, J X Lin","doi":"10.3760/cma.j.cn441530-20230826-00069","DOIUrl":"10.3760/cma.j.cn441530-20230826-00069","url":null,"abstract":"<p><p><b>Objectives:</b> To construct a nomogram prediction model using common preoperative indicators for early weight loss (EWL) 1 year after laparoscopic sleeve gastrectomy (LSG). <b>Methods:</b> Relevant data of obese patients who had undergone LSG from January 2015 to May 2022 in Fujian Medical University Union Hospital and Quanzhou First Hospital Affiliated Fujian Medical University were analyzed. Patients with a history of major abdominal surgery, severe gastroesophageal reflux disease, pregnancy within 1 year after surgery, or who were lost to follow-up were excluded, resulting in a total of 200 patients in the study (190 from Fujian Medical University Union Hospital and 10 from Quanzhou First Hospital Affiliated Fujian Medical University). The participants were 51 men and 149 women of a mean age 29.9±8.2 years and a body mass index (BMI) 38.7±6.5 kg/m<sup>2</sup>. All patients in this group underwent standardized LSG procedure. Achieving ideal weight (BMI≤25 kg/m<sup>2</sup>) 1 year after LSG was defined as goal of EWL. Logistic regression analyses were performed to identify factors that independently influenced EWL. These factors were incorporated into the nomogram model. Receiver operating characteristic (ROC) curves (the larger the area under the curve [AUC], the better the predictive ability and accuracy of the model), likelihood ratio test (higher likelihood ratio indicates greater model homogeneity), decision curve analysis (higher net benefit indicates a better model), Akaike information criterion (AIC; smaller AIC indicates a better model), and Bayesian information criterion (BIC; smaller BIC indicates a better model) were used to validate the predictive ability of the column line diagram model. <b>Results:</b> In this study of 200 obese patients who underwent LSG surgery, 136 achieved EWL goal, whereas the remaining 64 did not. The rate of EWL goal achievement of the entire group was 68.0%. Compared with patients who did not achieve EWL goal, those who did had lower BMI, alanine transaminase, aspartate transaminase, triglycerides, and higher cholesterol. Additionally, the proportion of female was higher and the proportions of patients with fatty liver and hypertension lower in those who achieved EWL goal (all <i>P</i><0.05). Univariate and multivariate logistic regression analysis revealed that preoperative BMI (OR=0.852, 95%CI: 0.796-0.912, <i>P</i><0.001), alanine transaminase (OR=0.992, 95%CI: 0.985-0.999, <i>P</i>=0.024), presence of fatty liver (OR=0.185, 95%CI: 0.038-0.887, <i>P</i>=0.035) and hypertension (OR=0.374, 95%CI: 0.144-0.969, <i>P</i>=0.043) were independently associated with failure to achieve EWL goal. Cholesterol (OR=1.428, 95%CI: 1.052-1.939, <i>P</i>=0.022) was independently associated with achieving EWL goal. We used the above variables to establish an EWL nomogram model. ROC analysis, the likelihood ratio test, decision curve analysis, and AIC all revealed that the predictive value of the model was better","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"26 11","pages":"1058-1063"},"PeriodicalIF":0.0,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136399522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华胃肠外科杂志Pub Date : 2023-11-25DOI: 10.3760/cma.j.cn441530-20230907-00080
{"title":"[Chinese expert consensus on the application of circulating tumor cell detection in the diagnosis and treatment of gastrointestinal neoplasms (2023 edition)].","authors":"","doi":"10.3760/cma.j.cn441530-20230907-00080","DOIUrl":"10.3760/cma.j.cn441530-20230907-00080","url":null,"abstract":"<p><p>Circulating tumor cell (CTC), as a novel tumor marker, has the characteristics of non-invasive, dynamic monitoring and high accuracy, and provides precise molecular characteristics of tumors and helps understand the changes in tumor development. Therefore, CTC has important clinical value in the dynamic monitoring of tumor progression. In order to standardize and guide the application of CTC detection in the diagnosis and treatment of gastrointestinal neoplasms, Gastric Cancer Group of Oncology Branch of Chinese Medical Association, Colorectal Cancer Professional Committee of Chinese Medical Doctor Association, Colorectal Cancer Professional Committee of Chinese Anti-Cancer Association, Gastric Cancer Professional Committee of Chinese Anti-Cancer Association, Digestive Tract Polyp and Precancerous Lesion Professional Committee of Chinese Anti-Cancer Association, jointly convened some domestic experts to discuss and formulate the Chinese expert consensus on the application of circulating tumor cell detection in the diagnosis and treatment of gastrointestinal neoplasms (2023 edition). The consensus provides opinions on the detection technology and clinical application of CTC detection in the diagnosis and treatment of gastrointestinal neoplasms, including the prediction of tumor prognosis, the monitoring of tumor recurrence and metastasis, the evaluation of treatment response, and the additional diagnostic value, providing guidance for clinical application.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"26 11","pages":"1001-1007"},"PeriodicalIF":0.0,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136399516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华胃肠外科杂志Pub Date : 2023-11-25DOI: 10.3760/cma.j.cn441530-20230828-00071
Q W Shen, Q Y Yao
{"title":"[Mission and vision of clinical research in bariatric and metabolic surgery].","authors":"Q W Shen, Q Y Yao","doi":"10.3760/cma.j.cn441530-20230828-00071","DOIUrl":"10.3760/cma.j.cn441530-20230828-00071","url":null,"abstract":"<p><p>Clinical research progress in bariatric and metabolism research had promoted the development in clinical practice. In U. S and Europe, pivotal scientific questions had been explored by clinical researchers, which brought the updating of guidelines, accumulation in key evidences, promotion of the consensus of metabolic benefits, following further development in scientific area. Compared to U. S and Europe, clinical practice in bariatric and metabolic surgery development in China started later. Clinical research in China just developed into initial phase with few achievements with high quality and breakthrough contribution. However, with wider practice, larger patient population and higher quality of surgery, clinical research in bariatric and metabolic surgery in China will go to a new stage through clinical research with standardized guidance, broad cooperation and clinical data digitalization and standardization.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"26 11","pages":"1035-1041"},"PeriodicalIF":0.0,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136399523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华胃肠外科杂志Pub Date : 2023-11-25DOI: 10.3760/cma.j.cn441530-20221230-00544
S L Dong, W H Chen, J Guo, Y L Liang, F Q Zhou, C C Wang, Z Y Dong
{"title":"[Efficacy analysis of laparoscopic sleeve gastrectomy in morbidly obese patients aged 10-21 years].","authors":"S L Dong, W H Chen, J Guo, Y L Liang, F Q Zhou, C C Wang, Z Y Dong","doi":"10.3760/cma.j.cn441530-20221230-00544","DOIUrl":"10.3760/cma.j.cn441530-20221230-00544","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the efficacy of laparoscopic sleeve gastrectomy (LSG) in morbidly obese patients aged 10 to 21 years. <b>Methods:</b> We conducted a retrospective analysis of clinical data from 89 out of 200 patients who underwent LSG at the Gastrointestinal Surgery/Weight Loss Center of the First Affiliated Hospital of Jinan University between January 2015 and December 2020. The primary outcome measures were the completion rate of LSG, the incidence of perioperative complications, and weight-related indicators 3, 6, 12, and ≥24 months postoperatively. Additionally, we compared glucose metabolism, lipid metabolism, vitamin levels, liver function, and other relevant biochemical variables before and after surgery. Normally distributed continuous data are presented as <i>x±s</i>. Because the numbers of patients at each follow-up time point were not identical with the number of patients in the study cohort preoperatively, independent sample <i>t</i>-tests were used for intergroup comparisons. Non-normally distributed continuous data are presented as <i>M</i>(<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>), and Mann-Whitney <i>U</i> tests were used for intergroup comparisons. <b>Results:</b> Among the 89 patients, 35 were male (39.3%), the mean age was (18±2) years, and mean body mass index (BMI) 38.5±4.8 kg/m²; 37 of the patients having a BMI greater than 40 kg/m². Additionally, 63 patients (70.8%) had fatty livers, 34 (38.2%) hyperuricemia, 31(34.8%) sleep apnea syndrome, 20 (22.4%) gastroesophageal reflux, eight (8.9%) type 2 diabetes, and two (2.2%) hypertension. All 89 patients underwent LSG surgery successfully, with no conversions to open surgery. During the perioperative period, there were no cases of major bleeding, gastric leakage, or infections. Notable postoperative symptoms included nausea, vomiting, and pain, most of which improved by the second postoperative day. BMI values 3, 6, and 12 months postoperatively had decreased to 31.5±5.8 kg/m², 28.6±4.3 kg/m², and 26.3±4.4 kg/m², respectively. All of these BMI values differed significantly from preoperative values (all <i>P</i><0.05). At 12 and ≥24 months postoperatively, the percentages of total weight loss were (31.3±9.3)% and (33.1±10.5)%, respectively, both differing significantly from 3 months postoperatively (20.5±5.1)% (all <i>P</i><0.05). The percentages of excess weight loss at 12 and ≥24 months postoperatively were 91% (70%, 113%) and 95% (74%, 118%) , respectively, both differing significantly from the percentage of total weight loss 3 months postoperatively (56% [45%, 72%]) (both <i>P</i><0.05). Alanine transaminase and aspartate transaminase serum concentrations decreased from preoperative values of 44.4 (25.5, 100.5) U/L and 29.0 (9.5, 48.0) U/L to 14.0 (10.8, 18.3) U/L and 13.0 (10.5, 17.3) U/L, respectively, ≥24 months postoperatively. Hemoglobin A1c decreased from 5.6 (5.3, 5.8)% preoperatively to ≥24 months postoperatively 5.3 (5.0, 5.4)%. High-density ","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"26 11","pages":"1064-1070"},"PeriodicalIF":0.0,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136399521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华胃肠外科杂志Pub Date : 2023-11-25DOI: 10.3760/cma.j.cn441530-20231007-00116
{"title":"[Chinese expert consensus on the diagnosis and treatment of sacrococcygeal pilonidal disease (2023 edition)].","authors":"","doi":"10.3760/cma.j.cn441530-20231007-00116","DOIUrl":"10.3760/cma.j.cn441530-20231007-00116","url":null,"abstract":"<p><p>Sacrococcygeal pilonidal disease(SPD) is an acquired disease intimately related to the presence of hair in the gluteal groove. Although its pathogenesis is still controversial, numerous treatment options are available for SPD including gluteal groove and surrounding skin hair removal, sinusectomy, open healing by secondary intention, primary closure, and local excision with flap reconstruction. Lacking of standardized diagnosis and treatment processes of SPD in China, Chinese Medical Doctor Association Anorectal Branch and its Clinical Guidelines Committee jointly organized experts in this field to form expert consensus opinion on the basis of summarizing latest research progress in China and abroad, experts' clinical experience and principles of evidence-based medicine. The expert group formed opinion in 12 terms of SPD diagnosis, risk factors, non-surgical treatment, surgical treatment, minimally invasive treatment, and wound management, and developed the \"Chinese expert consensus on the diagnosis and treatment of sacrococcygeal pilonidal disease (2023 edition)\" after rounds of discussion and revision, to improve the diagnosis and treatment of SPD.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"26 11","pages":"1008-1016"},"PeriodicalIF":0.0,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136399517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华胃肠外科杂志Pub Date : 2023-10-25DOI: 10.3760/cma.j.cn441530-20230918-00094
{"title":"[Criteria of enterostomy complications: classification and grading (2023 edition)].","authors":"","doi":"10.3760/cma.j.cn441530-20230918-00094","DOIUrl":"10.3760/cma.j.cn441530-20230918-00094","url":null,"abstract":"<p><p>Enterostomy-related complications are common in abdominal surgery. The incidence enterostomy-related complications varies according to the type and location of stoma, surgical procedure, and patient characteristics. Currently, there are no uniform criteria wopldwide for the classification of enterostomy complications. Previous classification of enterostomy-related complications were based on time of occurrence, clinical manifestations, or anatomical changes, etc., lacking uniformity and reproducibility. The concept and diagnostic criteria of complications are not yet clearly defined; and it is difficult to accurately determine the relationship between their severity, intervention, and medical cost. Moreover, surgeons and enterostomal therapists differ significantly in their concerns, cognition, and management principles for stoma-related complications. Therefore,the Chinese Ostomy Collaboration Group (COCG), together with the Wound, Ostomy, and Continence Nursing Committee of Chinese Nursing Association, the Colon and Rectal Surgeon Committee of Surgeon Branch of Chinese Medical Doctor Association, the Committee of Colorectal Cancer of Chinese Anti-Cancer Association, and the Colorectal Surgery Group of Surgery Branch of the Chinese Medical Association, jointly drafted the criteria for the classification and grading of enterostomy complications. We hope this criteria will facilitate prospective data collection, clinical diagnosis, treatment, medical training and education.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"26 10","pages":"915-921"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华胃肠外科杂志Pub Date : 2023-10-25DOI: 10.3760/cma.j.cn441530-20230706-00238
Y Liu, C L Yutaka, L X Toshiyuki, Y Li
{"title":"[Japanese practice of comprehensive treatment for peritoneal metastasis of gastric cancer].","authors":"Y Liu, C L Yutaka, L X Toshiyuki, Y Li","doi":"10.3760/cma.j.cn441530-20230706-00238","DOIUrl":"10.3760/cma.j.cn441530-20230706-00238","url":null,"abstract":"<p><p>Patients with peritoneal metastasis (PM) from gastric cancer (GC) have a poor prognosis. Surgery or systemic treatment alone hardly improves the prognosis and overall survival (OS). A newly developed comprehensive treatment involving a combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has been used to treat patients with PM from GC. The Peritoneal Dissemination Center of Kishiwada Tokushukai Hospital in Japan has been committed to treating patients with PM from GC. Selected patients undergo laparoscopic hyperthermic intraperitoneal chemotherapy (LHIPEC), preoperative intraperitoneal (IP) chemotherapy, and systemic chemotherapy that includes intravenous and oral chemotherapy prior to surgery. CRS plus HIPEC is then performed to achieve complete cytoreduction. Postoperative IP chemotherapy or systemic chemotherapy is also administered to nearly all patients. The results demonstrate that comprehensive treatment, including neoadjuvant chemotherapy and CRS plus HIPEC, can significantly improve the prognosis and OS of selected patients with PM from GC.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"26 10","pages":"992-996"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华胃肠外科杂志Pub Date : 2023-10-25DOI: 10.3760/cma.j.cn441530-20230816-00050
Z F Chen, Z Liu
{"title":"[Radiation-induced intestinal fibrosis: pathological assessment and pharmacological prevention].","authors":"Z F Chen, Z Liu","doi":"10.3760/cma.j.cn441530-20230816-00050","DOIUrl":"10.3760/cma.j.cn441530-20230816-00050","url":null,"abstract":"<p><p>Although radiotherapy can improve the local control rate of tumors and prolong the survival period of patients, it can also lead to long-term adverse effects such as radiation-induced intestinal fibrosis. Radiation-induced intestinal fibrosis has a high incidence and poses significant challenges to treatment, severely impacting the quality of life of patients. Combining findings from domestic and international research, along with experiences of our center, this article mainly discusses the pathological changes of radiation-induced intestinal fibrosis, as well as the current status and challenges of pathological assessment and pharmacological prevention of this condition. At present, there is no definitive method to reverse the fibrotic pathological changes. Thus, the prevention of fibrosis is a crucial issue to be resolved. In the meantime, there is a lack of ideal assessment methods and effective preventive medications in clinical practice. It is necessary to enhance both basic and clinical research, thoroughly investigate the pathogenesis of the disease, and identify effective intervention targets to promote the diagnosis and treatment of radiation-induced intestinal fibrosis.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"26 10","pages":"935-939"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华胃肠外科杂志Pub Date : 2023-10-25DOI: 10.3760/cma.j.cn441530-20230829-00073
{"title":"[Standardized surgical procedure of conformal sphincter-preservation operation for low rectal cancer (2023 edition)].","authors":"","doi":"10.3760/cma.j.cn441530-20230829-00073","DOIUrl":"10.3760/cma.j.cn441530-20230829-00073","url":null,"abstract":"<p><p>Conformal sphincter-preservation operation (CSPO) is considered the effective surgical technique for preserving the sphincter in cases of low rectal cancer. Accurate preoperative diagnosis and staging, reasonable selection of surgical approaches and technique, standardized perioperative management, and postoperative rehabilitation are the keys to ensuring the oncological clearance and functional preservation of CSPO. However, there is currently a lack of standardized surgical procedure for implementing CSPO in China. Therefore, the Colorectal Surgery Group of Surgery Branch of the Chinese Medical Association,along with the Colorectal Cancer Committee of the Chinese Medical Doctor Association and the Anorectal Branch of Chinese Medical Doctor Association, gathered experts in colorectal surgery to discuss and establish this standardized surgical procedure of CSPO. This standard, based on the latest evidence from literature, expert experiences, and China national condition, focuses on the definition, classification, pelvic anatomy, surgical techniques, postoperative complications, and perioperative care of CSPO. It aims to guide the standardized clinical practice of CSPO in China.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"26 10","pages":"907-914"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
中华胃肠外科杂志Pub Date : 2023-10-25DOI: 10.3760/cma.j.cn441530-20230808-00039
Y Wang
{"title":"[Imaging diagnosis and evaluation of radiation-induced intestinal injury].","authors":"Y Wang","doi":"10.3760/cma.j.cn441530-20230808-00039","DOIUrl":"10.3760/cma.j.cn441530-20230808-00039","url":null,"abstract":"<p><p>Radiation-induced intestinal injury significantly impacts the quality of life and even prognosis of patients. Timely diagnosis and accurate assessment are crucial in clinical practice. Imaging examinations play a vital role in the diagnosis and evaluation of radiation-induced intestinal injury. CT offers fast scanning speed and wide coverage but has limited soft tissue resolution. On the other hand, MRI offers superior soft tissue resolution, along with the capability for multi-sequence and multi-parameter imaging, and the ability to assess the effect of tumor treatment. However, its scanning range is restricted. Endorectal ultrasound enables observation of rectal wall thickness, submucosal blood flow signals, and the development of micro-ulcers and fistulas. The key imaging features of radiation-induced intestinal injury include intestinal wall thickening, layered enhancement on contrast-enhanced scans, fistula formation, and abscess formation, and so on. Previous studies have established correlations between certain imaging features and the severity as well as prognosis of the disease. Nonetheless, these imaging features lack specificity, and require differentiation from tumors, ischemic changes, and other intestinal inflammatory lesions, considering the patient's radiotherapy history in conjunction with the imaging findings.</p>","PeriodicalId":23959,"journal":{"name":"中华胃肠外科杂志","volume":"26 10","pages":"929-934"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41239147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}